The global oncological phototherapy market size reached USD 165.4 Million in 2022 and is expected to register a revenue CAGR of 8.0% during the forecast period, according to the latest analysis by Emergen Research. Increasing prevalence of cancers and rising demand for minimally non-invasive technology are some of the key factors driving revenue growth of the market over the forecast period. The National Board of Health and Welfare reports that the Cancer Registry in the U.S. received reports of 68,318 malignant tumors for 62,555 individuals in 2020. The number of individuals with a cancer diagnosis was significantly larger than the number of cancer-related fatalities. https://www.emergenresearch.com/industry-report/oncological-phototherapy-market